Shortened Tracer Uptake Time in GA-68-DOTATOC-PET of Meningiomas Does Not Impair Diagnostic Accuracy and PET Volume Definition.

DOTATOC PET meningioma radiosurgery

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
13 Dec 2020
Historique:
received: 24 11 2020
revised: 11 12 2020
accepted: 11 12 2020
entrez: 16 12 2020
pubmed: 17 12 2020
medline: 17 12 2020
Statut: epublish

Résumé

Ga-68-DOTATOC-PET/MRI can affect the planning target volume (PTV) definition of meningiomas before radiosurgery. A shorter tracer uptake time before image acquisition could allow the examination of more patients. The aim of this study was to investigate if shortening uptake time is possible without compromising diagnostic accuracy and PET volume. Fifteen patients (

Identifiants

pubmed: 33322125
pii: diagnostics10121084
doi: 10.3390/diagnostics10121084
pmc: PMC7763245
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Lancet Oncol. 2016 Sep;17(9):e383-91
pubmed: 27599143
Neuro Oncol. 2016 Jul;18(7):1021-7
pubmed: 26865086
Neuro Oncol. 2016 Oct 1;18(suppl_5):v1-v75
pubmed: 28475809
Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1409-15
pubmed: 22669255
J Neurosurg. 2015 Jan;122(1):4-23
pubmed: 25343186
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):222-7
pubmed: 16488553
Neurosurg Focus. 2019 Jun 1;46(6):E9
pubmed: 31153151
Nuklearmedizin. 2018 Feb;57(1):4-17
pubmed: 29536494
J Nucl Med. 2001 Jul;42(7):1053-6
pubmed: 11438627
Neuro Oncol. 2016 Nov;18(11):1538-1547
pubmed: 27106404
J Nucl Med. 2017 Sep;58(9):1519-1525
pubmed: 28254872
Radiat Oncol. 2018 Jun 14;13(1):110
pubmed: 29898747
Radiother Oncol. 2015 Feb;114(2):230-8
pubmed: 25701297
Neuro Oncol. 2015 Feb;17(2):312-9
pubmed: 25008094
Springerplus. 2015 Jan 30;4:37
pubmed: 25674497
Clin Nucl Med. 2017 Jan;42(1):e1-e7
pubmed: 27607161
Neuro Oncol. 2017 Nov 29;19(12):1576-1587
pubmed: 28605532
Cancer Biother Radiopharm. 2020 Apr;35(3):163-166
pubmed: 32196363
J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9
pubmed: 11895036
Clin Nucl Med. 2017 Mar;42(3):180-186
pubmed: 28033217
Cancers (Basel). 2019 Sep 22;11(10):
pubmed: 31546734
J Nucl Med. 2005 May;46(5):763-9
pubmed: 15872348
Neuroradiol J. 2018 Feb;31(1):18-26
pubmed: 29206077
J Neurosurg. 2017 Sep;127(3):660-669
pubmed: 27982767
Clin Nucl Med. 2017 Sep;42(9):669-674
pubmed: 28682844
Am J Nucl Med Mol Imaging. 2018 Oct 20;8(5):311-331
pubmed: 30510849
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):68-73
pubmed: 22575489
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931

Auteurs

Josefine Graef (J)

Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.

Carolin Senger (C)

Department of Radiation Oncology and Radiotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.

Christoph Wetz (C)

Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.

Alexander D J Baur (ADJ)

Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.
Conradia Charlottenburg MVZ GmbH, 10627 Berlin, Germany.

Anne K Kluge (AK)

Department of Radiation Oncology and Radiotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.

Mathias Lukas (M)

Department of Diagnostic and Interventional Radiology, Universitätsmedizin Leipzig, 04103 Leipzig, Germany.
Department of Diagnostic and Interventional Radiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health,13353 Berlin, Germany.

Julian M M Rogasch (JMM)

Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.

Thula C Walter-Rittel (TC)

Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.

David Kohnert (D)

Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.

Marcus Makowski (M)

Department of Diagnostic and Interventional Radiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health,13353 Berlin, Germany.
Department of Diagnostic and Interventional Radiology, School of Medicine, Technical University of Munich, 81675 Munich, Germany.

Güliz Acker (G)

Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
Berlin Institute of Health (BIH), Charité University Hospital Berlin and MDC, 10178 Berlin, Germany.

Kai Huang (K)

Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.

Volker Budach (V)

Department of Radiation Oncology and Radiotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.

Holger Amthauer (H)

Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.

Imke Schatka (I)

Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.

Christian Furth (C)

Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.

Classifications MeSH